Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Short Interest Down 49.6% in August

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) was the target of a large decline in short interest in the month of August. As of August 14th, there was short interest totaling 3,812 shares, a decline of 49.6% from the July 30th total of 7,564 shares. Approximately 0.0% of the shares of the company are sold short. Based on an average daily volume of 150,205 shares, the days-to-cover ratio is currently 0.0 days.

Institutional Trading of Shionogi & Co., Ltd. Unsponsored ADR

A hedge fund recently bought a new position in Shionogi & Co., Ltd. Unsponsored ADR stock. Birmingham Capital Management Co. Inc. AL acquired a new stake in Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm acquired 6,950 shares of the company’s stock, valued at approximately $257,000. Hedge funds and other institutional investors own 1.92% of the company’s stock.

Shionogi & Co., Ltd. Unsponsored ADR Trading Down 0.6%

SGIOY opened at $9.04 on Friday. The stock has a market capitalization of $15.39 billion, a price-to-earnings ratio of 9.04, a P/E/G ratio of 3.34 and a beta of 0.08. The company has a quick ratio of 1.46, a current ratio of 1.58 and a debt-to-equity ratio of 0.01. Shionogi & Co., Ltd. Unsponsored ADR has a twelve month low of $7.65 and a twelve month high of $12.00. The company has a 50-day simple moving average of $8.85 and a 200 day simple moving average of $9.76.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) last released its earnings results on Monday, August 3rd. The company reported $0.36 EPS for the quarter, beating the consensus estimate of $0.18 by $0.18. The firm had revenue of $1.04 billion for the quarter, compared to analyst estimates of $970.69 million. Shionogi & Co., Ltd. Unsponsored ADR had a net margin of 46.67% and a return on equity of 16.47%. Analysts predict that Shionogi & Co., Ltd. Unsponsored ADR will post 0.8 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts have commented on SGIOY shares. Jefferies Financial Group raised Shionogi & Co., Ltd. Unsponsored ADR from a “hold” rating to a “strong-buy” rating in a report on Tuesday, July 14th. The Goldman Sachs Group upgraded shares of Shionogi & Co., Ltd. Unsponsored ADR from a “hold” rating to a “strong-buy” rating in a research note on Monday, June 15th. Finally, Zacks Research raised shares of Shionogi & Co., Ltd. Unsponsored ADR from a “strong sell” rating to a “hold” rating in a research report on Monday, May 25th. Two investment analysts have rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, Shionogi & Co., Ltd. Unsponsored ADR has an average rating of “Buy”.

Shionogi & Co., Ltd. Unsponsored ADR Company Profile

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.